Breath Biomarkers in Liver Disease: A Case Study
A webinar to introduce how breath analysis can be used to gain a deeper understanding and earlier diagnosis of liver disease.
Please complete the form at the end of this page to view the webinar.
Watch our webinar ‘Breath as a Biomarker Matrix: A Case Study in Liver Disease’ on demand. The webinar is hosted by Owlstone Medical’s Lead Translational Scientist, Dr. Giuseppe Ferrandino, and Head of Business Development, Research Products & Services, Europe & RoW (Rest of the World), Dr. Elizabeth Crone. Our experts introduce how breath analysis can be used to gain a deeper understanding of liver disease, as well as provide an avenue for the earlier diagnosis of liver disease.
Breath Biopsy® offers a revolutionary, non-invasive method for diagnosing liver diseases by analyzing volatile organic compounds (VOCs) in exhaled breath. Liver disease alters metabolic processes, leading to the release of unique VOCs detectable via breath analysis. This approach provides clinicians with a safer, quicker, and cost-effective alternative to traditional diagnostics like liver biopsies or blood tests.
Breath analysis has many unique advantages that can be useful in liver disease research. One key application is in measuring volatile microbial metabolites that are related to liver disease. Volatile metabolites can travel through blood circulation to the lungs where they readily volatilize into air and are subsequently exhaled. Several case studies are covered in our webinar, as well as the possibilities for at-home breath collection and analysis for decentralized clinical trial designs, and improved diagnostic tools.
Breath analysis could pave the way for widespread use in early diagnosis, monitoring, and treatment of liver diseases, offering a non-invasive and accessible alternative to traditional methods. By integrating breath biomarker technology into clinical practice, healthcare providers could revolutionize liver disease care worldwide.
This webinar is for researchers interested in exploring the use of non-invasive breath biomarkers in relation to liver disease, and anymore with an interest in learning more about the potential of breath research for clinical practice.
To watch this webinar, please fill in the form below.